Global Bioimplants Market 2017-2021

  • ID: 4417838
  • Report
  • Region: Global
  • 101 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott
  • C. R. Bard
  • Corin
  • Edwards Lifesciences
  • Kasios
  • Mediplus
  • MORE
About Bioimplants

Bioimplants are used to regularize the physiological functions or augment the functioning of an existing biological structure to treat the cause of various chronic diseases such as cardiovascular diseases (CVDs), neurological disorders, dental issues, and ophthalmic complications. The demand for bioimplants is growing from cardiology, vascular therapy, orthopedic, trauma, spine, dental, and wound care. Bioengineered products such as cardiac pacemakers and orthopedic artificial implants are implanted inside the patient's body.

The analysts forecast the global bioimplants market to grow at a CAGR of 10.20% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global bioimplants market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Bioimplants Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott
  • DePuy Synthes
  • Medtronic
  • Stryker
  • Zimmer Biomet
Other prominent vendors
  • B. Braun
  • Cook Medical
  • Corin
  • C. R. Bard
  • Edwards Lifesciences
  • FH Orthopedics
  • Kasios
  • KLS martin GROUP
  • Mediplus
  • W. L. Gore & Associates
  • Wright Medical technology
Market drivers
  • Rising prevalence of chronic diseases
  • For a full, detailed list, view the full report
Market challenges
  • High cost of bioimplants
  • For a full, detailed list, view the full report
Market trends
  • Increasing demand for minimally invasive surgeries
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • C. R. Bard
  • Corin
  • Edwards Lifesciences
  • Kasios
  • Mediplus
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION
  • Overview
PART 05: MARKET LANDSCAPE
  • Overview
  • Market size and forecast
  • Five forces analysis
PART 06: SEGMENTATION BY PRODUCT TYPE
  • Overview
  • Cardiovascular bioimplants
  • Orthopedic bioimplants
  • Dental bioimplants
  • Ophthalmic bioimplants
  • Neurostimulation bioimplants
  • Others
PART 07: SEGMENTATION BY IMPLANT MATERIAL
  • Overview
  • Ceramics
  • Biomaterial metals
  • Alloys
  • Biological materials
  • Polymers
PART 08: SEGMENTATION BY END-USER
  • Overview
  • Comparison by end-user
  • Hospitals
  • ASCs
  • Research institutions
  • Market opportunity by End-user
PART 09: SEGMENTATION BY GEOGRAPHY
  • Overview
  • Regional comparison
  • Americas
  • EMEA
  • APAC
  • Key leading countries
  • Market opportunity
PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS
  • Increasing demand for minimally invasive surgeries
  • Rise of medical tourism
PART 13: VENDOR LANDSCAPE
  • Competitive landscape
  • Other prominent vendors
PART 14: VENDOR ANALYSIS
  • Vendor overview
  • Abbott
  • DePuy Synthes
  • Medtronic
  • Stryker
  • Zimmer Biomet
PART 15: APPENDIX
  • List of abbreviations
List of Exhibits
Exhibit 01: Global bioimplants market: Segmentation
Exhibit 02: Global bioimplants market 2016-2021 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global bioimplants market: Segmentation by product type 2016 (% share)
Exhibit 05: Global bioimplants market: Segmentation by end-user 2016-2021 (% share)
Exhibit 06: Global bioimplants market: Comparison by end-user
Exhibit 07: Global bioimplants market by hospitals 2016-2021 ($ billions)
Exhibit 08: Global bioimplants market by hospitals: Year-over-year growth 2017-2021 (%)
Exhibit 09: Global bioimplants market by ASCs 2016-2021 ($ billions)
Exhibit 10: Global bioimplants market by ASCs: Year-over-year growth 2017-2021 (%)
Exhibit 11: Global bioimplants market by research institutions 2016-2021 ($ billions)
Exhibit 12: Global bioimplants market by research institutions: Year-over-year growth 2017-2021 (%)
Exhibit 13: Global bioimplants market: Segmentation by geography 2016-2021 (% share)
Exhibit 14: Global bioimplants market: Regional comparison
Exhibit 15: Bioimplants market in Americas 2016-2021 ($ billions)
Exhibit 16: Bioimplants market in Americas: Year-over-year growth 2017-2021 (%)
Exhibit 17: Bioimplants market in EMEA 2016-2021 ($ billions)
Exhibit 18: Bioimplants market in EMEA: Year-over-year growth 2017-2021 (%)
Exhibit 19: Bioimplants market in APAC 2016-2021 ($ billions)
Exhibit 20: Bioimplants market in APAC: Year-over-year growth 2017-2021 (%)
Exhibit 21: Global bioimplants market: Key leading countries 2017 (%)
Exhibit 22: Characteristics of biomaterials used in bioimplants
Exhibit 23: Common post-surgical complications associated with bioimplants
Exhibit 24: Global bioimplants market: Competitive structure analysis 2016
Exhibit 25: Abbott: Key highlights
Exhibit 26: Abbott: Strength assessment
Exhibit 27: Abbott: Strategy assessment
Exhibit 28: Abbott: Opportunity assessment
Exhibit 29: DePuy Synthes: Key highlights
Exhibit 30: DePuy Synthes: Strength assessment
Exhibit 31: DePuy Synthes: Strategy assessment
Exhibit 32: DePuy Synthes: Opportunity assessment
Exhibit 33: Medtronic: Key highlights
Exhibit 34: Medtronic: Strength assessment
Exhibit 35: Medtronic: Strategy assessment
Exhibit 36: Medtronic: Opportunity assessment
Exhibit 37: Stryker: Key highlights
Exhibit 38: Stryker: Strength assessment
Exhibit 39: Stryker: Strategy assessment
Exhibit 40: Stryker: Opportunity assessment
Exhibit 41: Zimmer Biomet: Key highlights
Exhibit 42: Zimmer Biomet: Strength assessment
Exhibit 43: Zimmer Biomet: Strategy assessment
Exhibit 44: Zimmer Biomet: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • C. R. Bard
  • Corin
  • Edwards Lifesciences
  • Kasios
  • Mediplus
  • MORE
New Report Released: - Global Bioimplants Market 2017-2021

The author of the report recognizes the following companies as the key players in the global bioimplants market: Abbott, DePuy Synthes, Medtronic, Stryker, and Zimmer Biomet.

Other Prominent Vendors in the market are: B. Braun, Cook Medical, Corin, C. R. Bard, Edwards Lifesciences, FH Orthopedics, Kasios, KLS martin GROUP, Mediplus, W. L. Gore & Associates, and Wright Medical technology.

Commenting on the report, an analyst from the research team said: “One trend in the market is increasing demand for minimally invasive surgeries. Minimally invasive surgeries involve creating a minute incision to reach the point of surgical intervention. Minimally invasive procedures such as laser surgery, endoscopy, and laparoscopy create small incisions, which significantly helps in reducing pain and morbidity and improve postoperative recovery.”

According to the report, one driver in the market is rising prevalence of chronic diseases. The demand for bioimplants has been increasing over the years due to the rising prevalence of chronic diseases such as CVDs, sensory and neurological diseases, orthopedic and spinal-related conditions, ophthalmic diseases, and dental diseases. Some of the common diseases chronic diseases are type 2 diabetes, obesity, stroke, cancer, obesity, arthritis, and heart diseases. With the increasing prevalence of diabetes, the risk CVDs also increases. Obesity is also one of the significant risk factors for type 2 diabetes.

Further, the report states that one challenge in the market is high cost of bioimplants. Currently, bioimplants are used to treat various chronic ailments such as type 2 diabetes, heart failure, obesity, and knee fracture. However, these implants are expensive as they are made from a combination of biological, mechanical, and optical elements. Bioimplants have properties that enable them to function inside the human body. Biomaterials have biomechanical properties, which are comparable to autogenous tissues. However, they do not have any side-effects. Some properties determine the suitability of materials for bioimplants.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott
  • DePuy Synthes
  • Medtronic
  • Stryker
  • Zimmer Biomet
  • B. Braun
  • Cook Medical
  • Corin
  • C. R. Bard
  • Edwards Lifesciences
  • FH Orthopedics
  • Kasios
  • KLS martin GROUP
  • Mediplus
  • W. L. Gore & Associates
  • Wright Medical technology.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll